Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Windlas Biotech Management Change

Windlass Biotech reports Mr. Ashok Kumar Windlass ceased as Executive Director, resigning for succession planning, effective 5 November 2026. He moves to Founder President, and Hitesh Windlass becomes Managing Director.

Source

BSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Windlas Biotech Ltd: key numbers

Share price
₹921.25
Market cap
₹1,934 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
29.1×Sector 37.9×
Promoter holding
63.31%+0.00% QoQ
FII holding
2.09%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Windlas Biotech Ltd

All →

Other management change announcements

All →